Last reviewed · How we verify
HSK47388
At a glance
| Generic name | HSK47388 |
|---|---|
| Sponsor | Haisco Pharmaceutical Group Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study for HSK47388 in Participants With Ulcerative Colitis (PHASE2)
- Food Effect Study of HSK47388 in Healthy Subjects (PHASE1)
- A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis (PHASE2)
- This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HSK47388 CI brief — competitive landscape report
- HSK47388 updates RSS · CI watch RSS
- Haisco Pharmaceutical Group Co., Ltd. portfolio CI